Identification of small-molecule inhibitors against Meso-2, 6-diaminopimelate dehydrogenase from porphyromonas gingivalis

5Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Species-specific antimicrobial therapy has the potential to combat the increasing threat of antibiotic resistance and alteration of the human microbiome. We therefore set out to demonstrate the beginning of a pathogen-selective drug discovery method using the periodontal pathogen Porphyromonas gingivalis as a model. Through our knowledge of metabolic networks and essential genes we identified a "druggable" essential target, meso-diaminopimelate dehydrogenase, which is found in a limited number of species. We adopted a highthroughput virtual screen method on the ZINC chemical library to select a group of potential small-molecule inhibitors. Meso-diaminopimelate dehydrogenase from P. gingivalis was first expressed and purified in Escherichia coli then characterized for enzymatic inhibitor screening studies. Several inhibitors with similar structural scaffolds containing a sulfonamide core and aromatic substituents showed dose-dependent inhibition. These compounds were further assayed showing reasonable whole-cell activity and the inhibition mechanism was determined. We conclude that the establishment of this target and screening strategy provides a model for the future development of new antimicrobials.

Cite

CITATION STYLE

APA

Stone, V. N., Parikh, H. I., El-Rami, F., Ge, X., Chen, W., Zhang, Y., … Xu, P. (2015). Identification of small-molecule inhibitors against Meso-2, 6-diaminopimelate dehydrogenase from porphyromonas gingivalis. PLoS ONE, 10(11). https://doi.org/10.1371/journal.pone.0141126

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free